A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease

Stopped early · Phase 3 · Has a placebo group

Conditions studied: Crohn Disease

In brief

This is a study to demonstrate the effect of oral ozanimod as maintenance therapy in participants with moderately to severely active Crohn's Disease.

Key facts

Study ID
NCT03464097
Run by
Celgene
People needed
550
Starts
2018-06-27
Expected to finish
2024-10-03
Last updated by the study team
2025-10-09

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.